EANS-Adhoc: LifeWatch AG
hires top Healthcare Executive to lead Sales
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
Company Information
16.09.2010
Stephen J. Zielinski appointed Senior Vice President of Sales of LifeWatch Corp.
Neuhausen am Rheinfall/ Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE) announced today the appointment of Stephen J. Zielinski as Senior Vice President of Sales of LifeWatch Corp., effective September 20, 2010. Brent Atwood, former Chief Sales Officer of LifeWatch Services, Inc., will pursue opportunities outside the company.
Mr. Stephen Zielinski brings to LifeWatch over 20 years of sales and sales management experience with leading firms in the cardiology and medical device industries. Mr. Zielinski has specialized in building and growing sales organizations. His past experience includes VP of Sales for Angiotech´s Interventional & Surgical products, where he managed a dozen regional managers and 120 sales representatives. Mr. Zielinski spent thirteen years with Boston Scientific (Minnesota, USA) where he was most recently the Director of Sales for the Peripheral & Vascular Division and the Cardiovascular Division. In addition, Mr Zielinski led the new product launch of Boston Scientific´s highly successful Taxus stent line. During his tenure at Boston Scientific, Mr. Zielinski also led the development and operation of a sales training division of 38 specialists and trainers and was responsible for the integration of sales force automation tools to over 300 sales representatives. Mr. Zielinski previously held senior sales management positions at various other firms such as CoAxia, Inc. (Minnesota, USA), an early stage company focusing on products for ischemic stroke. Mr. Zielinski holds a Bachelor of Science degree in Business Management from Purdue University.
"We are very excited that Steve is joining LifeWatch as we expand our advanced wireless healthcare services to other remote patient monitoring markets," stated Brent Cohen, CEO of LifeWatch AG, the parent company of LifeWatch Corp. "His deep, cardiac-related experience and proven management skills will be invaluable assets as we continue to expand our presence in the cardiac monitoring market and as we enter new service industries such as home sleep testing."
About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telemedicine systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider. LifeWatch has also introduced a new program for Home Sleep Testing of Obstructive Sleep Apnea (OSA) patients under the brand name NiteWatch. For additional information, please visit www.lifewatch.com.
Sign-up for customized E-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward- looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward- looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward- looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.
end of announcement euro adhoc
Further inquiry note:
For further information please contact:
Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 24 48 | E-mail wkim@lifewatch.com
Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch
Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard